Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor

NCT01684098 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent or Metastatic Cancer
Head and Neck Cancer
Pancreas Cancer
Bladder Cancer
Testicular Cancer

Interventions

DRUG: Tc 99m EC20

Sponsor

Endocyte